Analyst Ratings For Genus plc (LON:GNS)
Today, Kepler Capital Markets reiterated its Hold rating on Genus plc (LON:GNS).
There are 4 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Genus plc (LON:GNS) is Hold with a consensus target price of GBX 2,365 per share, a potential .
Some recent analyst ratings include
- 9/13/2018-Genus plc (LON:GNS) had its Hold rating reiterated by Kepler Capital Markets
- 9/6/2018-Genus plc (LON:GNS) had its Hold rating reiterated by Liberum Capital with a GBX 2,400 price target
- 3/1/2018-Genus plc (LON:GNS) had its Hold rating reiterated by Berenberg Bank with a GBX 1,800 price target
- 11/16/2017-Genus plc (LON:GNS) had its Buy rating reiterated by N+1 Singer
- 9/7/2017-Genus plc (LON:GNS) had its Hold rating reiterated by Numis Securities with a GBX 1,815 price target
About Genus plc (LON:GNS)
Genus plc, together with its subsidiaries, engages in the application of quantitative genetics and biotechnology for animal breeding in the porcine and bovine sectors. It operates through three segments: Genus PIC, Genus ABS, and Research and Development. The company sells sows, boars, and semen under the PIC name to breed pigs with various characteristics for pork production. It also sells bull semen and embryos that are delivered through artificial insemination to breed diary and beef cattle with various characteristics for milk and beef production under the ABS name, as well as provides various in vitro fertilization services under the IVB name. The company serves pork, beef, and dairy farmers in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. Genus plc was incorporated in 1994 and is headquartered in Basingstoke, the United Kingdom.
Recent Trading Activity for Genus plc (LON:GNS)
Shares of Genus plc closed the previous trading session at 501,00 up +13,00 0,52 % with shares trading hands.
